SYNERGISTIC COMBINATION OF AZITHROMYCIN AND SULFADIAZINE FOR TREATMENT OF TOXOPLASMOSIS IN MICE

被引:10
作者
ARAUJO, FG
LIN, T
REMINGTON, JS
机构
[1] PALO ALTO MED FDN,RES INST,860 BRYANT ST,PALO ALTO,CA 94301
[2] STANFORD UNIV,MED CTR,SCH MED,DEPT MED,DIV INFECT DIS,STANFORD,CA 94305
关键词
D O I
10.1007/BF01971278
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Experiments were performed in vivo in a mouse model of acute toxoplasmosis to evaluate the effectiveness of the combination azithromycin/sulfadiazine. Azithromycin alone or sulfadiazine alone, at doses that did not provide any protection against death due to toxoplasmosis, were remarkably and significantly synergistic against murine toxoplasmosis when administered in combination.
引用
收藏
页码:71 / 73
页数:3
相关论文
共 16 条
[1]   INTERACTION OF SULFONAMIDE AND SULFONE COMPOUNDS WITH TOXOPLASMA-GONDII DIHYDROPTEROATE SYNTHASE [J].
ALLEGRA, CJ ;
BOARMAN, D ;
KOVACS, JA ;
MORRISON, P ;
BEAVER, J ;
CHABNER, BA ;
MASUR, H .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) :371-379
[2]   AZITHROMYCIN, A MACROLIDE ANTIBIOTIC WITH POTENT ACTIVITY AGAINST TOXOPLASMA-GONDII [J].
ARAUJO, FG ;
GUPTILL, DR ;
REMINGTON, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) :755-757
[3]   INVIVO ACTIVITY OF THE MACROLIDE ANTIBIOTICS AZITHROMYCIN, ROXITHROMYCIN AND SPIRAMYCIN AGAINST TOXOPLASMA-GONDII [J].
ARAUJO, FG ;
SHEPARD, RM ;
REMINGTON, JS .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (06) :519-524
[4]  
Brooks R. G., 1987, Antimicrobial Agents Annual, V2, P297
[5]   INVITRO EFFECTS OF 4 MACROLIDES (ROXITHROMYCIN, SPIRAMYCIN, AZITHROMYCIN [CP-62,993], AND A-56268) ON TOXOPLASMA-GONDII [J].
CHANG, HR ;
PECHERE, JCF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (04) :524-529
[6]   TREATMENT OF TOXOPLASMIC ENCEPHALITIS WITH INTRAVENOUS CLINDAMYCIN [J].
DANNEMANN, BR ;
ISRAELSKI, DM ;
REMINGTON, JS .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (11) :2477-2482
[7]   DIRECT AGGLUTINATION-TEST FOR DIAGNOSIS OF TOXOPLASMA INFECTION - METHOD FOR INCREASING SENSITIVITY AND SPECIFICITY [J].
DESMONTS, G ;
REMINGTON, JS .
JOURNAL OF CLINICAL MICROBIOLOGY, 1980, 11 (06) :562-568
[8]  
EYLES DON E., 1955, ANTIBIOT AND CHEMOTHER, V5, P529
[9]   PHARMACOKINETIC AND INVIVO STUDIES WITH AZITHROMYCIN (CP-62,993), A NEW MACROLIDE WITH AN EXTENDED HALF-LIFE AND EXCELLENT TISSUE DISTRIBUTION [J].
GIRARD, AE ;
GIRARD, D ;
ENGLISH, AR ;
GOOTZ, TD ;
CIMOCHOWSKI, CR ;
FAIELLA, JA ;
HASKELL, SL ;
RETSEMA, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (12) :1948-1954
[10]   INVITRO AND INVIVO UPTAKE OF AZITHROMYCIN (CP-62,993) BY PHAGOCYTIC-CELLS - POSSIBLE MECHANISM OF DELIVERY AND RELEASE AT SITES OF INFECTION [J].
GLADUE, RP ;
BRIGHT, GM ;
ISAACSON, RE ;
NEWBORG, MF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (03) :277-282